Compare stocks
Add stockDates End of financial period
| #1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | |
|---|---|---|---|---|---|---|---|---|
| Remove TEVA Pharmaceut... | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
Profit ROIC / ROE/ROA / ROE / ROA
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| TEVA Pharmaceutical ... (ROE/ROA) | 28.5% | 33.6% | 29.7% | 25.2% |
Growth Sales and OCF growth / Sales and net income growth
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| TEVA Pharmaceutical ... | 14.8% | 14.7% | 13.7% | -21.6% |
Payout Shareholder distributions / net income
| #1 | #2 | #3 | #4 | #5 | |
|---|---|---|---|---|---|
| TEVA Pharmaceutical ... | 0% | 0% | 0% | 0% | 0% |
Safety Equity/assets and OCF stability / Equity/assets and net income stability
| Balance | Stability | |
|---|---|---|
| TEVA Pharmaceutical ... | 18.6% | 57.4% |
Price Earnings and FCF yield / Earnings and book yield
| Earnings | FCF / Book | |
|---|---|---|
| TEVA Pharmaceutical ... | $0.51 | $0.98 |
